Equity Overview
Price & Market Data
Price: $0.231
Daily Change: +$0.00105 / 0.45%
Range: $0.216 - $0.243
Market Cap: $47,956,816
Volume: 288,241
Performance Metrics
1 Week: 5.96%
1 Month: -23.57%
3 Months: -34.49%
6 Months: -82.63%
1 Year: -86.90%
YTD: -39.02%
Details
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom. Its lead product, Plogosertib or plogo, is a PLK1 inhibitor, in solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.